This inventor holds 1 USPTO granted patent. Top assignee: Hokkaido University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovative Mind of Reiko Yoshida: A Breakthrough in Ebola Virus Therapy
Introduction
Reiko Yoshida, a pioneering inventor based in Hokkaido, Japan, has made significant contributions to the field of medical research. With a focus on combating viruses, Yoshida has developed a groundbreaking patent aimed at providing effective therapy against the ebolavirus, a disease that poses severe global health challenges.
Latest Patents
Yoshida holds a patent for a monoclonal antibody that neutralizes the infectivity of all ebola viruses. The invention addresses a critical need for a neutralizing monoclonal antibody useful in antibody therapy for ebolavirus. The patented monoclonal antibody or its antigen-binding fragment targets an internal fusion loop of the ebola virus glycoprotein (GP), effectively neutralizing its biological activity. This advancement represents a substantial step forward in the fight against ebola.
Career Highlights
Currently affiliated with the National University Corporation Hokkaido University, Yoshida has dedicated his career to innovative research that transforms medical therapies. His work has not only contributed to scientific understanding but also enhanced therapeutic approaches in virology. The successful patent reflects years of meticulous research and dedication to public health.
Collaborations
Reiko Yoshida collaborates with esteemed colleagues, including Ayato Takada and Wakako Furuyama, who contribute to the dynamic research environment within their institution. Working alongside talented individuals helps foster an atmosphere of innovation and accelerates the development of new therapeutic solutions.
Conclusion
Reiko Yoshida's contributions to the field of virology, exemplified by his patent for a monoclonal antibody against ebolavirus, highlight the impact of dedicated researchers on global health. His work at Hokkaido University showcases the importance of innovation and collaboration in developing effective medical therapies. With ongoing research and potential for further advancements, Yoshida continues to inspire the future of science and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
